August 3, 2020
UC San Diego researchers discovered that people with an inactive RNA-editing enzyme respond better to cancer immunotherapy, and inhibitors of the enzyme help mice with difficult-to-treat cancers live longer.
August 19, 2019
…collaboration that will enhance clinical psychology education—the first of its kind within the University of California system. His gift has supported cohorts of 50 undergraduates to pursue careers in clinical mental health services. UC San Diego Health: Cancer Vaccine Iris and Matthew Strauss Iris and Matthew Strauss hold a great…
August 6, 2024
Through a unique and long-standing collaboration, electrical engineers at UC San Diego are embedded in Jacobs Retina Center to partner with ophthalmologists to develop better computer vision, AI, and image processing tools to help physicians diagnose patients faster and more accurately; predict which drugs will be most successful for specific…
June 29, 2022
Using brain organoids, UC San Diego researchers discover mutational commonalities between muscular dystrophy type 1 and Rett syndrome, suggesting the potential of a similar treatment for both.
May 13, 2024
An experimental treatment made from a plant virus is effective at protecting against a broad range of metastatic cancers in mice, shows a new study from the University of California San Diego. The treatment, composed of nanoparticles fashioned from the cowpea mosaic virus—a virus that infects black-eyed pea plants—showed remarkable…
December 15, 2022
Researchers at UC San Diego provide new insights into the pathology of limbic predominate age-related TDP-43 encephalopathy, which mimics Alzheimer’s, making it very difficult to identify in living patients.
October 17, 2016
The National Academy of Medicine (NAM) announced today the election of two new members from University of California San Diego School of Medicine: James F. Sallis, PhD, Distinguished Professor and chief of the Division of Behavioral Medicine, and Cheryl Ann Marie Anderson, PhD, associate professor. Both are in the Department…
September 8, 2015
Using “mini-brains” built with induced pluripotent stem cells derived from patients with a rare, but devastating, neurological disorder, researchers at University of California, San Diego School of Medicine say they have identified a drug candidate that appears to “rescue” dysfunctional cells by suppressing a critical genetic alteration.
August 5, 2020
Researchers at UC San Diego School of Medicine report successfully implanting specialized grafts of neural stem cells directly into spinal cord injuries in mice, then documenting how the grafts grew and filled the injury sites, mimicking the animals’ existing neuronal network.
April 11, 2022
Researchers at UC San Diego School of Medicine and Moores Cancer Center at UC San Diego Health, with collaborators, have further elucidated how ovarian cancer tumors defy immunotherapy, identifying new molecular targets that might boost immune response.
